Intuitive Surgical Update (ISRG)
Intuitive Surgical (ISRG) penetrated the previous 52-week price floor in today’s bloodbath along with the rest of the market. While still bullish on the company over the long run (even more reasonable valuation now, P/E 17), the previously suggested limit order should have limited losses to those who took heed. A true value investor would be bottoms up focused and ignore overall market behavior however the markets are trading to the technicals and hard to avoid.
An Argument for Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) is an undervalued equity whose position in the medical device industry places it for prime appreciation in the years to come. Taking a conservative estimate of 13% EPS growth (far less than current rates) and a 21 P/E (far less than historical), the stock which is presently trading in the low $90’s at a P/E of 17.7 should approach $225 by 2014. This would represent an annual appreciation of 20%.